Open Journal of Medicinal Chemistry
Vol.3 No.1(2013), Paper ID 29463, 6
pages
DOI:10.4236/ojmc.2013.31001
New Gene Therapy Strategies for the Deletion of Exon 44 of Dystrophin Gene Based on Gene Editing by TALENs
Ping Li, Yunzhi Pan, Alice S. S. Li, Aijuan Sun, Jia Zhang, H. L. Gao, Pierre Sirois, Kai Li
Department of Molecular Diagnostics and Biopharmaceutics, College of Pharmaceutical Science, Soochow University, Suzhou, China
Department of Molecular Diagnostics and Biopharmaceutics, College of Pharmaceutical Science, Soochow University, Suzhou, China
University of Waterloo, Waterloo, Canada
Department of Molecular Diagnostics and Biopharmaceutics, College of Pharmaceutical Science, Soochow University, Suzhou, China
Gene Core, The Genomics Institute of the Novartis Research Foundation, San Diego, USA
DNA Sequencing Core Laboratory, City of Hope National Medical Center, Duarte, USA
Centre Hospitalier de l’Université Laval Research Center, Laval University, Quebec, Canada
Department of Molecular Diagnostics and Biopharmaceutics, College of Pharmaceutical Science, Soochow University, Suzhou, China
Copyright © 2013 Ping Li, Yunzhi Pan, Alice S. S. Li, Aijuan Sun, Jia Zhang, H. L. Gao, Pierre Sirois, Kai Li et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
P. Li, Y. Pan, A. Li, A. Sun, J. Zhang, H. Gao, P. Sirois and K. Li, "New Gene Therapy Strategies for the Deletion of Exon 44 of Dystrophin Gene Based on Gene Editing by TALENs,"
Open Journal of Medicinal Chemistry, Vol. 3 No. 1, 2013, pp. 1-6. doi:
10.4236/ojmc.2013.31001.